Key result
Glu298Asp polymorphism in the endothelial nitric oxide synthase gene did not increase the susceptibility to coronary and carotid arteries disease in the studied Egyptian population.
Why the study?
Is the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene associated with atherosclerotic coronary and carotid arterial disease in an Egyptian population?
Case-Control (n=95)
Is the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene associated with atherosclerotic coronary and carotid arterial disease in an Egyptian population?
The Glu298Asp polymorphism of the eNOS gene is not associated with increased susceptibility to coronary and carotid artery disease in the Egyptian population.
Answers are grounded in this paper and cite their sources.
No association in this Egyptian cohort does not support genetic testing for risk stratification; leaves open relevance in other populations.
Atherosclerosis is partly a heritable disorder. Various genetic polymorphisms have been linked to the atherosclerotic process and its complications. Glu298Asp polymorphism of endothelial nitric oxide synthase gene is one such genetic marker for atherosclerosis. To study the relationship between endothelial nitric oxide synthase gene polymorphism and atherosclerotic coronary and carotid arterial disease in Egyptian population. Our study included 95 Egyptian patients with Egyptian father and mother, classified into two groups: Group 1; 63 patients with ischemic heart disease and Group 2; 32 control subjects and subjected to careful history taking, thorough clinical examination, standard twelve-lead surface electrocardiogram, routine laboratory investigations, echo Doppler study, carotid arterial duplex, invasive coronary angiography and analysis of the endothelial NOS3 gene polymorphism using PCR–RFLP for detection of different genotype variants (Glu/Glu (GG), Glu/Asp (GT) and Asp/Asp (TT) genotype). Glu298Asp polymorphism in the endothelial nitric oxide synthase gene did not increase the susceptibility to coronary and carotid arteries disease in the studied patients.
No takes yet. Share an insight, caveat, or question.
Razek et al. (2014) conducted a case-control in Ischemic heart disease (n=95). Glu298Asp polymorphism of endothelial nitric oxide synthase (NOS3) gene vs. Control subjects was evaluated on Susceptibility to coronary and carotid arteries disease. Glu298Asp polymorphism in the endothelial nitric oxide synthase gene did not increase the susceptibility to coronary and carotid arteries disease in the studied Egyptian population.
Synapse has enriched 10 related papers. Consider them for comparative context: